Tiziana Life Sciences is trading at $1.16, up 10.48% after hours, with the move appearing mainly linked to broader biotech strength.

  • Shares gained 17.99% during the September 23, 2026 regular session.
  • The company’s latest official announcement, on September 21, covered completion of the final patient visit in its Phase 2a INFORM-MS trial.
  • No September 23 announcement directly explains the after-hours move.